- AMR ×
-
JMM Editor’s Choice: using Komodo dragon DNA to create antibiotics
December 11, 2020
This month Dr Marcello Riggio discusses “Komodo-dragon cathelicidin-inspired peptides are antibacterial against carbapenem-resistant Klebsiella pneumoniae” which was chosen as Editor’s Choice for the November issue of the Journal of Medical Microbiology.
-
JMM Editor’s Choice: an international network to tackle AMR
November 23, 2020
This month, Dr Tim Inglis discusses ‘The TACTIC experience: establishing an international, interdisciplinary network to tackle antimicrobial resistance’ which was chosen as Editor’s Choice for the October issue of the Journal of Medical Microbiology.
-
JMM Editor’s Choice: does sub-culturing of positive MRSA blood cultures affect vancomycin MICs?
September 7, 2020
The Journal of Medical Microbiology (JMM) is a journal published by the Microbiology Society, focused on providing comprehensive coverage of medical, dental and veterinary microbiology and infectious diseases, including bacteriology, virology, mycology and parasitology. This month, Dr Steve Michell discusses the paper ‘Does sub-culturing of positive MRSA blood cultures affect vancomycin MICs?’ which was chosen as Editor’s Choice for the August issue of JMM.
-
Antimicrobial resistance: the next pandemic?
August 26, 2020
It is now estimated 700,000 people die each year as a result of drug resistant diseases, with this number predicted to increase to over 10 million deaths per year by 2050. The current COVID-19 pandemic appears to have accelerated the threat of antimicrobial resistance (AMR), as many patients admitted to hospitals displaying COVID-19 symptoms are treated with antibiotics to reduce their chances of contracting secondary bacterial infections, making resistant bacteria more common.
-
New antibiotics needed: Helicobacter pylori
July 23, 2020
In 2017, the World Health Organization (WHO) published the ’12 Priority Pathogens’: a list of 12 microbes that are becoming increasingly resistant to current antimicrobials. These 12 pathogens are thought by WHO to pose the greatest threat to human health.
-
Microbiology Editor’s Choice: a regulatory protein linked to Acinetobacter baumannii virulence
July 1, 2020
Each month, a manuscript published in our flagship journal Microbiology is chosen by a member of the Editorial Board. This month, the paper is titled ‘A response regulator protein with antar domain, AvnR, in Acinetobacter baumannii ATCC 17978 impacts its virulence and amino acid metabolism’ and was chosen by Professor David Grainger.
-
A sustainable future and antimicrobial resistance
June 22, 2020
As part of our 'A Sustainable Future' policy project, the Microbiology Society's policy team have produced three special episodes of Microbe Talk to explore the role of microbiology in addressing some of the world’s biggest challenges. In this episode, Emily speaks with Professor Laura Piddock from the University of Birmingham, who is currently on secondment as the Director of Scientific Affairs, Global Antibiotic Research and Development Partnership. In the second half of the episode, Emily speaks with Dr Anne Leonard, research fellow at the University of Exeter. Listen to the episode to find out how research into antimicrobial resistance fits into the United Nations Sustainable Development Goals (UN SDGs).
-
JMM Editor’s Choice: mechanisms of colistin resistance
May 15, 2020
The Journal of Medical Microbiology (JMM) is a journal published by the Microbiology Society, focused on providing comprehensive coverage of medical, dental and veterinary microbiology and infectious diseases, including bacteriology, virology, mycology and parasitology. This month, Dr Kim Hardie discusses the paper ‘Mutations in the two component regulator systems PmrAB and PhoPQ give rise to increased colistin resistance in Citrobacter and Enterobacter spp.’ which was selected as Editor’s Choice from the April issue of JMM.
